Deduct
发表于 2025-3-26 21:48:00
http://reply.papertrans.cn/39/3865/386454/386454_31.png
AER
发表于 2025-3-27 04:26:11
http://reply.papertrans.cn/39/3865/386454/386454_32.png
就职
发表于 2025-3-27 06:02:28
http://reply.papertrans.cn/39/3865/386454/386454_33.png
delegate
发表于 2025-3-27 11:12:26
Treatment Algorithms for Intraocular Retinoblastoma: An Ocular Oncologist’s Perspectiveimportant clinical information on these new modalities that has not been previously published in the literature, allowing the ocular oncologist to navigate the path between tumor relapse and potential treatment toxicities.
irreducible
发表于 2025-3-27 14:55:19
978-3-031-08252-8The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
扫兴
发表于 2025-3-27 19:14:17
https://doi.org/10.1007/978-3-031-08250-4ocular oncology; global care; eye cancer; retinoblastoma; pediatric oncology; uveal melanoma; radiation; en
visceral-fat
发表于 2025-3-28 01:49:19
Bhavna V. Chawla,Mary E. AronowOffers an international perspective on the varied spectrum of adult and pediatric eye cancers.Includes international and multidisciplinary contributors.Broken up into seven sections and includes a sec
纺织品
发表于 2025-3-28 03:02:03
http://reply.papertrans.cn/39/3865/386454/386454_38.png
Harass
发表于 2025-3-28 08:33:23
http://reply.papertrans.cn/39/3865/386454/386454_39.png
Retrieval
发表于 2025-3-28 12:01:23
https://doi.org/10.1007/978-3-319-22309-4 when treating rare, orphan disease. With a variety of goals spanning from education to mentorship to patient advocacy, these societies inspire research, collaboration, and change. In this chapter, we highlight four different interest groups: two focused on young ocular oncologists (and pathologists